Orphan Drugs & Rare Diseases- Innovative Strategies for Getting Orphan Drugs to Where They Are Needed

-

The call to treat rare diseases has become increasingly greater around the world than ever before. Supportive organisations including patient groups, national health authorities, health trusts, academia, HTAs, pharmaceutical and biotechnical companies are now progressively growing in numbers and sophistication in their approaches to medicinal care for those with rare and ultra-rare diseases.

SMi’s Orphan Drugs & Rare Diseases conference will present briefings from key opinion leaders, those with hands-on experience of regulating new drug discoveries, companies that have already developed advanced orphan drugs & successfully been granted orphan medicine status and selected experts in the field. Our expert speakers will offer unique insights into cutting-edge international developments taking place in: expanding the reach of medicine to previously untreatable and unreachable patients with rare diseases; different regulatory and policy environments; new drug discoveries; innovative business strategies & funding & financing models, and the importance of partnerships with patient groups and those at the point-of-care.

Key benefits of attending:

• Learn about health technology assessment protocols and market access in the EU and globally
• Network with key regulators of orphan medicines and policy makers for national rare disease treatment
• Discover successful funding, financing and economic models for orphan drug development and translational research
• Analyse industry case studies showing how R&D and market access costs can be reduced
• Understand the latest developments in ultra-rare diseases studies and new medicines for them
• Explore how organisations are merging research, resources and expertise in the race to cure rare diseases

Hear keynote addresses from:
• Dr. Edmund Jessop, Medical Advisor, National Commissioning Group for Highly Specialised Services, NHS
• Josie Godfrey, Head of Policy and Coordination, AGNSS

• Stephen Nutt, Executive Officer, Rare Disease UK

• Carlos R. Camozzi, MD, PhD, MBA, Vice President, Chief Medical Officer, uniQure B.V.

• Marisa Jaconi, Vice-Director and Founder, Swiss Institute of Cell Therapies (SICT)

• Samantha Parker, Director of External Affairs and Rare Disease Partnerships, Orphan Europe


Location:
Copthorne Tara Hotel, London
Scarsdale Place,
Kensington,
Kensington & Chelsea,
London,
W8 5SR
UK


Organizer: SMi Group Ltd

8 Oct 2012

UPCOMING FEATURED EVENTS 1 2 Next 
ASCB 20146 Dec 2014 Read
PepTalk: The Protein Science Week19 Jan 2015 Read
SLAS20157 Feb 2015 Read
Electronic Data in Clinical Trials24 Feb 2015 Read
Pittcon Conference and Expo 20158 Mar 2015 Read
Biotherapeutics Analytical Summit9 Mar 2015 Read
Extracellular Biomarkers Summit16 Mar 2015 Read
Targeting Mitochondrial Dysfunction & Toxicity19 Mar 2015 Read


ALL UPCOMING EVENTS
1 2 Next 
Pharmacovigilance, Drug Safety and Risk Management 201426 Nov 2014 Read
9th Annual Cold Chain Distribution Conference and Exhibition2 Dec 2014 Read
ASCB 20146 Dec 2014 Read
Revolutionizing Next-Generation Sequencing: Tools and Technologies15 Jan 2015 Read
PepTalk: The Protein Science Week19 Jan 2015 Read
Pharmaceutical Microbiology21 Jan 2015 Read
MedLab26 Jan 2015 Read
7th Annual Pre-Filled Syringes Conference and Exhibition28 Jan 2015 Read
The Biologics Congress2 Feb 2015 Read
Biophysical Society 59th Annual Meeting7 Feb 2015 Read
SLAS20157 Feb 2015 Read
Parallel Trade9 Feb 2015 Read
Advances and Progress in Drug Design 201516 Feb 2015 Read
RNA Therapeutics16 Feb 2015 Read
Electronic Data in Clinical Trials24 Feb 2015 Read
Cell Culture World Congress24 Feb 2015 Read
13th International Congress on Targeted Anticancer Therapies2 Mar 2015 Read
Pittcon Conference and Expo 20158 Mar 2015 Read
Biotherapeutics Analytical Summit9 Mar 2015 Read
Extracellular Biomarkers Summit16 Mar 2015 Read
MEDLAB Asia Pacific18 Mar 2015 Read
Targeting Mitochondrial Dysfunction & Toxicity19 Mar 2015 Read
ACS National Meeting and Exposition22 Mar 2015 Read
Arablab23 Mar 2015 Read
Superbugs and Superdrugs25 Mar 2015 Read
Experimental Biology28 Mar 2015 Read
World Vaccine Congress US7 Apr 2015 Read
Analytica Vietnam15 Apr 2015 Read
AACR (American Association for Cancer Research)18 Apr 2015 Read
Bio-IT World21 Apr 2015 Read